Sunshine Overseas: Transparency Rules For Life Sciences

Law360, New York (October 10, 2012, 2:14 PM EDT) -- In the wake of the U.S. Physician Payments Sunshine Act (signed into law in March 2010), European, Asian and Australian governmental bodies and trade associations have been rapidly adopting “Sunshine-like” transparency and disclosure requirements applicable to life sciences companies.

These new requirements vary in scope, rigor and reporting deadlines — creating a patchwork of international requirements — and present significant compliance challenges for life sciences companies that conduct ex-U.S. activities such as clinical trials and international advisory boards, among others.

For instance, in December 2011, France...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.